SEC Form 4 · accession 0001209191-15-069481
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan A. Knudson
Officer — Chief Financial Officer
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2015 | M | 3,000 | $1.22 | A | 3,492 | D | |
| Common Stock | Sep 1, 2015 | S | 3,000 | $11.33 | D | 492 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.22 | Sep 1, 2015 | M | 3,000 | D | — | Feb 11, 2020 | Common Stock | 3,000 | 30,718 | D |
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Option shares are fully vested.